Physician’s Briefing Weekly Coronavirus Roundup
FDA Approves Pfizer Booster Shots for Seniors, High-Risk Americans
Exactly who qualifies as high risk because of health or work reasons is not yet clear
Many Oral Anticancer Drugs Require Prior Authorization
Median time to drug receipt was seven days; prior authorization was associated with delayed time to drug receipt
Survival Up With Tebentafusp in Metastatic Uveal Melanoma
Overall survival longer with tebentafusp for HLA*02:01-positive patients with previously untreated metastatic uveal melanoma
RAI Therapy for Hyperthyroidism Not Tied to Overall Cancer Risk
However, linear radiation dose-response association between radioactive iodine and solid cancer mortality seen in two studies
HPV Vaccine Will Have Modest Impact on Oropharynx Cancer Incidence by 2045
However, reductions in oropharynx cancer incidence should be seen among young and middle-aged adults
Metformin May Prolong Gestation in Women With Preterm Preeclampsia
No difference seen in circulating concentrations of soluble fms-like tyrosine kinase-1, placental growth factor, soluble endoglin
First Biosimilar Approved for Macular Degeneration, Other Eye Conditions
Biosimilar to Lucentis approved to treat neovascular age-related macular degeneration, macular edema, myopic choroidal neovascularization
CDC Expert Panel to Weigh In on Vaccine Boosters
Panel will deliberate which high-risk groups should get a booster shot
U.S. to Buy 500 Million More COVID-19 Vaccine Doses for Global Donation
Some 160 million shots from the United States have been given to more than 100 countries
